Fresenius SE & Co. KGaA (FRE) - Stock & Dividends

Exchange: XETRA Stock Exchange • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0005785604

Dialyzers, Dialysis Machines, IV Generic Drugs, Enteral Products

Fresenius SE & Co. KGaA is a leading healthcare company that provides life-enhancing products and services to patients with chronic illnesses. The company operates through four main segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.

The Fresenius Medical Care segment is dedicated to helping patients with chronic kidney failure. This segment offers a range of products and services, including dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services to support patients with kidney disease.

The Fresenius Kabi segment focuses on providing therapy and care to critically and chronically ill patients. This segment offers a broad portfolio of products, including I.V. generic drugs, biosimilar drugs for autoimmune diseases and oncology, enteral and parenteral nutrition products, medical technologies, and disposables, infusions pumps, apheresis machines, cell therapy devices, and other products.

The Fresenius Helios segment operates clinical and nursing care facilities, providing high-quality healthcare services to patients. Meanwhile, the Fresenius Vamed segment offers services to hospitals and other healthcare facilities, including operational management of healthcare facilities and services to patients.

Fresenius SE & Co. KGaA has a rich history, dating back to 1912, and is headquartered in Bad Homburg vor der Höhe, Germany. Today, the company is a global leader in the healthcare industry, committed to improving the lives of patients worldwide. You can learn more about Fresenius SE & Co. KGaA at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Fresenius SE & Co. KGaA (FRE) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Fresenius SE & Co. KGaA (FRE) - Stock & Dividends

FRE Stock Overview

Market Cap in USD 18,043m
Sector Healthcare
Industry Medical Care Facilities
GiC SubIndustry Health Care Facilities
TER 0.00%
IPO / Inception

FRE Stock Ratings

Growth 5y -34.6
Fundamental 9.05
Dividend 5.85
Rel. Performance vs Sector -0.21
Analysts -
Fair Price Momentum 27.06 EUR
Fair Price DCF 164.38 EUR

FRE Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 2.87%
Payout Consistency 92.5%

FRE Growth Ratios

Growth 12m 12.64%
Growth Correlation 12m -6%
Growth Correlation 3m 75%
CAGR 5y -7.62%
CAGR/Mean DD 5y -0.28
Sharpe Ratio 12m 0.30
Alpha vs SP500 12m -10.94
Beta vs SP500 5y weekly 0.83
ValueRay RSI 21.49
Volatility GJR Garch 1y 21.56%
Price / SMA 50 -0.88%
Price / SMA 200 3.2%
Current Volume 2213.4k
Average Volume 20d 1058.2k

External Links for FRE Stock

Fund Manager Positions
What is the price of FRE stocks?
As of June 22, 2024, the stock is trading at EUR 28.07 with a total of 2,213,442 shares traded.
Over the past week, the price has changed by -5.04%, over one month by +2.00%, over three months by +13.92% and over the past year by +10.38%.
What are the forecast for FRE stock price target?
According to ValueRays Forecast Model, FRE Fresenius SE & Co. KGaA will be worth about 29.3 in June 2025. The stock is currently trading at 28.07. This means that the stock has a potential upside of +4.2%.
Issuer Forecast Upside
Wallstreet Target Price 36 28.3
Analysts Target Price - -
ValueRay Target Price 29.3 4.20